Table 1 Baseline characteristics of 250 prostate cancer patients
From: Prognostic value of changes in quality of life scores in prostate cancer
Characteristic | Categories | Number | Percent |
|---|---|---|---|
Age at diagnosis (years) | ▪ Mean | 59.7 | |
▪ Median | 59.0 | ||
▪ Range | 37-79 | ||
Vital status | ▪ Death | 39 | 15.6 |
▪ Alive | 211 | 84.4 | |
Treatment history | ▪ Newly diagnosed | 149 | 59.6 |
▪ Previously treated | 101 | 40.4 | |
Stage at diagnosis | ▪ Stage I | 3 | 1.2 |
▪ Stage II | 168 | 67.2 | |
▪ Stage III | 31 | 12.4 | |
▪ Stage IV | 48 | 19.2 | |
Chemotherapy at CTCA | ▪ No | 220 | 88.0 |
▪ Yes | 30 | 12.0 | |
Radiotherapy at CTCA | ▪ No | 63 | 25.2 |
▪ Yes | 187 | 74.8 | |
Hormone therapy at CTCA | ▪ No | 85 | 34.0 |
▪ Yes | 165 | 66.0 | |
Surgery at CTCA | ▪ No | 247 | 98.8 |
▪ Yes | 3 | 1.2 |